Armstrong Fleming & Moore’s Oracle ORCL Stock Holding History

Armstrong Fleming & Moore’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-822	Closed	-$231K	–	112
2025 Q3	$231K	Buy	+822	New	+$209K	0.11%	100

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Armstrong Fleming & Moore's ORCL Position: Q4 2025 in Review

Armstrong Fleming & Moore sold out of Oracle (ORCL) in Q4 2025, closing a stake of 822 shares — an estimated $231K sold.

Armstrong Fleming & Moore first reported a position in ORCL in Q3 2025 and held it in 1 quarter. The position peaked at $231K in Q3 2025. 3,770 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

Armstrong Fleming & Moore reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
Armstrong Fleming & Moore sold 822 Oracle shares in Q4 2025, an estimated $231K.
Armstrong Fleming & Moore first reported a position in Oracle in Q3 2025 and held it in 1 quarter.
Armstrong Fleming & Moore's Oracle position peaked at $231K in Q3 2025.
3,770 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Armstrong Fleming & Moore's 13F filing for Q4 2025, filed 16 Jan 2026.